Proteinases and proteinase inhibitors in experimental shock states.
D000614:Aminocaproates / Q000494:pharmacology; D000707:Anaphylaxis / Q000401:mortality / Q000503:physiopathology; D000818:Animals; D007611:Aprotinin / Q000494:pharmacology; D001158:Arteries / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002056:Burns; D004285:Dogs; D005260:Female; D006168:Guinea Pigs; D051379:Mice; D009130:Muscle, Smooth / Q000187:drug effects; D010447:Peptide Hydrolases / Q000494:pharmacology*; D011480:Protease Inhibitors; D051381:Rats; D012119:Respiration / Q000187:drug effects; D012769:Shock / Q000201:enzymology / Q000401:mortality; D012774:Shock, Traumatic / Q000503:physiopathology*; D013916:Thrombelastography; D014361:Trypsin Inhibitors / Q000494:pharmacology
D000614:Aminocaproates; D011480:Protease Inhibitors; D014361:Trypsin Inhibitors; D007611:Aprotinin; D010447:Peptide Hydrolases